Data for ST000344
| Metabolite structure | All data | F1 | F2 |
|---|---|---|---|
| 1_Ceramide (d18:1/17:0) iSTD | 261264.67 | 204142.83 | |
| 1_CUDA iSTD | 24301.17 | 22082.33 | |
| 1_FA (16:0)-d3 iSTD | 6357590.67 | 5305179.17 | |
| 1_LPC (17:0) iSTD | 31850.67 | 23443.83 | |
| 1_LPE (17:1) iSTD | 29356.83 | 22422.67 | |
| 1_MAG (17:0/0:0/0:0) iSTD | 584037.50 | 421558.83 | |
| 1_PC (12:0/13:0) iSTD | 4016.00 | 2902.50 | |
| 1_PE (17:0/17:0) iSTD | 39435.67 | 35314.83 | |
| 1_PG (17:0/17:0) iSTD | 576673.33 | 444927.17 | |
| 1_SM (d18:1/17:0) iSTD | 8445.33 | 5662.00 | |
| Ceramide (d32:1) | 10875.83 | 10298.50 | |
| Ceramide (d34:0) | 67623.50 | 41187.83 | |
| Ceramide (d34:1) | 381487.83 | 345900.83 | |
| Ceramide (d34:2) | 7517.17 | 9066.17 | |
| Ceramide (d36:1) | 53461.17 | 38985.33 | |
| Ceramide (d38:1) | 9895.83 | 5474.17 | |
| Ceramide (d40:0) | 15274.00 | 6660.83 | |
| Ceramide (d40:1) | 127105.17 | 75104.33 | |
| Ceramide (d40:2) | 6531.17 | 4578.83 | |
| Ceramide (d42:0) | 17452.83 | 7208.83 | |
| Ceramide (d42:1) | 269383.33 | 170889.50 | |
| Ceramide (d42:2) A | 201691.83 | 165477.33 | |
| FA (14:0) | 16906.00 | 12472.50 | |
| FA (15:0) | 4711.33 | 3994.50 | |
| FA (16:0) | 234168.67 | 204517.50 | |
| FA (16:1) | 8683.00 | 8094.67 | |
| FA (17:0) A | 15893.67 | 13603.33 | |
| FA (17:0) B | 4347.00 | 3731.33 | |
| FA (18:0) | 1317382.17 | 1016893.33 | |
| FA (18:1) | 170885.17 | 142872.50 | |
| FA (20:0) | 22227.67 | 16346.67 | |
| FA (20:1) | 4066.50 | 2812.33 | |
| FA (22:0) | 6417.17 | 5882.33 | |
| FA (22:1) | 3867.17 | 2526.50 | |
| FA (24:0) | 40630.17 | 25166.33 | |
| FA (24:1) | 7463.67 | 4037.67 | |
| FA (26:0) | 4640.83 | 3911.67 | |
| GlcCer (d38:1) | 2411.33 | 1895.50 | |
| GlcCer (d40:1) | 34962.83 | 26857.33 | |
| GlcCer (d42:1) | 53194.17 | 44228.00 | |
| GlcCer (d42:2) | 31223.17 | 32314.00 | |
| LPC (16:0) | 2948.17 | 2022.33 | |
| LPC (18:0) B | 2913.83 | 1631.50 | |
| PC (32:0) | 7000.33 | 6338.83 | |
| PC (32:2) | 2656.00 | 2664.17 | |
| PC (36:1) | 60277.17 | 48160.83 | |
| PC (36:2) | 35032.67 | 34917.67 | |
| PC (38:2) | 3026.50 | 3229.17 | |
| PC (p-34:0) or PC (o-34:1) | 14091.67 | 11895.83 | |
| PC (p-34:1) or PC (o-34:2) B | 3897.50 | 2763.33 | |
| PE (34:1) | 50236.83 | 40149.50 | |
| PE (p-34:1) or PE (o-34:2) | 260360.33 | 191660.50 | |
| PE (p-34:2) or PE (o-34:3) | 5422.50 | 3405.83 | |
| PE (p-36:1) or PE (o-36:2) | 152306.67 | 117535.67 | |
| SM (d32:1) | 4509.50 | 4870.83 | |
| SM (d34:0) | 13905.33 | 11525.67 | |
| SM (d34:1) | 104202.00 | 106165.00 | |
| SM (d34:2) | 3778.33 | 5071.83 | |
| SM (d36:1) | 6578.67 | 5537.17 | |
| SM (d40:1) | 13585.83 | 10343.50 | |
| SM (d42:2) A | 24103.33 | 23045.00 |
Factors:
| F1 | Treatment:Control |
| F2 | Treatment:Lipid Supplement |
